Paid Type 2 Diabetes Clinical Trial

Candace Kastanis

Written by Candace Kastanis

Chemistry B.S. | UC Davis | Clinical Lab Technician

Updated & Fact Checked 7/25/26

What are paid diabetes type-2 clinical trials?

how to find clinical trials

Type 2 diabetes is a chronic disorder involving the way the body regulates and uses sugar (glucose) as a fuel. Paid diabetes type 2 clinical trials aim to discover how a specific drug or treatment intervention may respond in certain individuals. The participants in these trials are paid a stipend for their medical expenses, travel expenditures, and compensation in exchange for volunteering for the study.

The clinical trial experience may include many routine visits, tests, and other treatment modalities to help navigate patients to the intended outcome. The clinical trial results help researchers gain greater insight into the causes and contributors unique to type-2 diabetes.

How do I find paid diabetes type 2 clinical trials for healthy volunteers near me?

Finding paid type 2 clinical trials near you begins with contacting your physician or medical provider. They may be able to recommend a study based on your health profile. We also recommend checking on our website for opportunities to participate in a paid clinical trial near you.

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Recruiting
HYPOTHESIS: Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) have distinct pathophysiologic etiologies. Therefore, therapeutic interventions designed to correct the specific underlying pathogenic abnormalities in IGT and IFG will be required to optimally prevent the progressive beta cell failure and development of overt type 2 diabetes.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
08/06/2024
Locations: The University of Texas Health Science Center at San Antonio, San Antonio, Texas
Conditions: Diabetes Mellitus, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG)
Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics
Recruiting
This trial will evaluate whether a particular type of circulating white blood cell, monocytes, from type 2 diabetics with high blood pressure and vitamin D deficiency vs. sufficiency will induce hormones that increase blood pressure.
Gender:
ALL
Ages:
Between 25 years and 80 years
Trial Updated:
07/23/2024
Locations: Barnes-Jewish & Washington University Diabetes Center, Saint Louis, Missouri +1 locations
Conditions: Diabetes Mellitus, Type 2, Hypertension, Vitamin D Deficiency
Low Dose Fat-Induced Insulin Resistance
Recruiting
The primary goal of this study is to determine the dose of fatty acids that acutely induces mild insulin resistance in healthy volunteers. We hypothesize that a low-dose of fatty acid infusion (Intralipid/heparin) will cause a mild insulin resistance. The dose of fatty acid infusion that reliably causes mild insulin resistance will be selected for use in future studies.
Gender:
ALL
Ages:
Between 18 years and 44 years
Trial Updated:
03/07/2025
Locations: University of Pennsylvania, Philadelphia, Pennsylvania
Conditions: Diabetes Mellitus, Type 2, Insulin Resistance, Insulin Sensitivity
Blood Markers of Early Pancreas Cancer
Recruiting
Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The investigators propose a longitudinal study of subjects at higher than average risk of PDAC in order to generate clinical data and bank serial blood specimens.
Gender:
ALL
Ages:
19 years and above
Trial Updated:
02/06/2025
Locations: Unversity of Nebraska Medical Center, Omaha, Nebraska
Conditions: Diabetes Mellitus, Type 2, PreDiabetes, Pancreas Cyst, Chronic Pancreatitis, Genetic Predisposition to Disease, Inherited Disease
Phenotyping Genetic Risk for Type 2 Diabetes
Recruiting
This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.
Gender:
ALL
Ages:
Between 10 years and 70 years
Trial Updated:
08/14/2024
Locations: Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania +1 locations
Conditions: Diabetes Mellitus, Type 2, Genetics
Surgical or Medical Treatment
Recruiting
This study will test the hypothesis that metabolic bariatric surgery will be more effective at providing durable glycemic control and reduce co-morbidities than intensive medical therapy in youth with type 2 diabetes.
Gender:
ALL
Ages:
Between 13 years and 19 years
Trial Updated:
02/10/2025
Locations: Children's Hospital Colorado, Aurora, Colorado +2 locations
Conditions: Diabetes Mellitus, Type 2, Pediatric Obesity, Bariatric Surgery Candidate
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
Recruiting
To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
08/21/2024
Locations: Metabolic Research Institute, Inc, West Palm Beach, Florida
Conditions: Diabetes Mellitus Type 2, Cardiovascular Diseases, Coronary Artery Disease, Cerebrovascular Disease, Peripheral Artery Disease
Increasing CGM Use Among Patients With T2D
Recruiting
Study Overview: This interventional study aims to assess whether training healthcare professionals (HCPs) increases the number of continuous glucose monitor (CGM) prescriptions for patients with Type 2 Diabetes in a Federally Qualified Health Center serving a predominantly Hispanic/Latino population. Research Questions: Does HCP training enhance CGM prescription rates in a primary care setting? Does receiving a CGM prescription lead to improved Type 2 Diabetes control, as measured by Hemoglob... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/17/2025
Locations: Innercare Inc, El Centro, California +1 locations
Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus Type 2 (T2DM)
Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
Recruiting
High-resistance, short-duration inspiratory muscle strength training (IMST) is a novel lifestyle intervention involving 30 inhalations against a resistive load which requires only \~5 min/day and is thus ideal for youth with T2D (Y-T2D). Investigators seek to 1: assess changes in casual and 24-hr SBP, endothelial function, and arterial stiffness after 3 months of IMST vs. sham training in Y-T2D, 2: Define changes in eGFR andalbuminuria after 3 months of IMST vs. sham in Y-T2D, 3: Interrogate mec... Read More
Gender:
ALL
Ages:
Between 14 years and 40 years
Trial Updated:
06/10/2025
Locations: Seattle Children's Hospital, Seattle, Washington +1 locations
Conditions: Diabetes Mellitus Type 2
HOPE Intervention for Fitness
Recruiting
We will test the HOPE intervention on changing behavior of people to exercise more (take more steps each day).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/06/2025
Locations: UC Irvine, Irvine, California
Conditions: Diabetes Mellitus Type 2

Who conducts paid diabetes type 2 clinical trials for healthy volunteers?

Paid diabetes type 2 clinical trials are typically hosted by pharmaceutical companies looking to bring a new therapeutic intervention to market. Other sponsors could include government public health agencies or privatized research entities because type 2 diabetes is considered a major health problem in America. The CDC estimates more than 37 million Americans have a type 2 diabetes diagnosis and suffer from accompanying health complications such as:

  • Heart disease and stroke
  • Impaired kidney function
  • Vision loss
  • Foot problems
  • Infections

Quick Facts: Paid Type 2 Diabetes Clinical Trials

  • Actively recruiting US studies (July 2026): 314 (ClinicalTrials.gov)
  • Typical eligibility: many medication trials look for an A1C in a set range, commonly around 7–10%, and often allow a stable metformin routine to continue
  • Typical compensation: $50–$100 per completed visit, often plus a continuous glucose monitor and supplies at no cost during the study
  • Cost to participate: $0 — study medication, visits, and lab work are covered
  • Related: many diabetes drugs are also studied for weight loss — see weight loss trials and obesity trials

Do I have to stop my current diabetes medication?

Usually not. Many type 2 diabetes trials are designed as add-on studies: you keep a stable dose of your existing medication, most often metformin, and the study drug or placebo is added on top. Some studies do require a washout of certain medications, and the consent form spells out exactly what changes. Never adjust your own medication for a trial without the study physician’s guidance — bring your current prescription list to the screening visit and the team will tell you whether you qualify as-is.

What are the advantages of participating in a paid Type 2 Diabetes clinical trial?

The primary advantage of participating in a paid type 2 clinical trial is an opportunity to receive a new treatment with no out-of-pocket costs that could help with your diabetes type 2-associated medical issues. Often, patients report life-long difficulties maintaining ideal insulin levels placing them at a higher risk for more complications. Participants find volunteering in paid clinical trials beneficial in their efforts to achieve better health outcomes.


What are the disadvantages of participating in a paid diabetes type 2 clinical trial?

With any new therapeutic drug interventions, there are many unknowns. It is not clear how it will affect certain individuals. Therefore, you could experience some uncomfortable side effects. Additionally, the clinical trial results can be less than satisfactory or if the clinical trial is randomized; you could receive a placebo vs. the actual drug candidate.


How does a paid diabetes type 2 trial work?

Type 2 Diabetes is a known contributor towards advanced diseases and conditions. Researchers are actively working to decipher the biological components that make one more prone to insulin balance problems, and how they respond to various therapies over time. Understanding these principles will help to save many lives in the future. Conducting clinical trials is best avenue to developing advances therapies to help those who do not respond to existing therapeutic regimens.

Participants may have to demonstrate a particular subset of type 2 diabetes historical profile. Meaning, you may have to be a certain age, gender, or ethnicity. This is because different patient populations are more prone to type 2 diabetes and respond inconsistently to existing medications warranting more advanced research. The eligibility criteria vary greatly with each clinical sponsor.

There are four phases of a clinical trial process that leads to FDA approval. Each phase seeks to determine a certain set of clinical results. Collectively, the clinical trial process is trying to measure the effectiveness and safety of the administered therapy in various patient populations.


What do researchers learn from conducting paid diabetes type 2 clinical trials?

Learning more detailed information about the causes and contributors to type 2 diabetes is of great concern to our medical community leaders. Statistics indicate that Type 2 diabetes is one of the leading causes of non-catastrophic limb loss. As such, the bio-medical community is eager to find more effective methods of treating those afflicted. One of the most valuable vehicles to study different treatment interventions is by conducting paid diabetes type 2 trials. Researchers are looking for important biomarkers to indicate:

  • How long a drug may affect insulin resistance in certain populations. (Half-Life)
  • Which drug interactions may pose a threat.
  • How a patient may respond in general (is the drug therapeutic as effective as those previously used).
  • How exercise and diet may improve the overall health of an individual with and without drug interventions.
  • If age, gender, and ethnicity play a role in how the targeted therapeutic may affect certain individuals.

Commonly Asked Questions (FAQs)

  • How much are paid diabetes type 2 clinical trial participants paid on average?

    Paid diabetes type 2 clinical trial participants typically receive a stipend for travel expenses, specific meal plans, exercise equipment, and drug or hospital stays. In addition, volunteers are paid in exchange for their participation. The payment amount varies depending on the type of trial and sponsor, the risk involved, and the anticipated length of the study.

  • How do I find out if I am eligible to participate in a paid diabetes type 2 clinical trial?

    Clinical trial and eligibility information relating to paid diabetes type 2 clinical trials normally entails a preexisting condition of the disease itself. The clinical study coordinator or team lead may determine eligibility based on failed previous drug interventions, the impact of your current health, overall risk factors.

    Study coordinators may also take an in-depth look at your behavioral health and lifestyle choices to determine if you are a good fit for the therapeutic intervention. For detailed information about a particular study, you can check on their website or personally speak with the clinical study coordinator.

  • Will participation in a paid diabetes type 2 clinical trial prevent me from leaving prior to completion?

    Withdrawing from a type 2 diabetes clinical trial is permitted for any reason. Most clinical care coordinators inform patients at the beginning of the clinical trial about what to expect during your participation.

    Common Reasons Cited by Participants for Discontinuing a Paid Diabetes Type 2 Clinical Trial

    • Adverse reactions from the study therapeutic type
    • Financial hardship or job conflict
    • Unplanned family circumstances such as trouble finding childcare, a move etc.
    • Discouragement
    • Adverse health situation
    • Transportation

  • What type of information is normally collected in paid diabetes type 2 clinical trials?

    Because type 2 diabetes is associated with fluctuations in insulin levels, participants will have to engage in continuous glucose monitoring. You may be outfitted with an approved medical device or asked to do self-blood testing at regular intervals. Researchers will collect a full scope of pre- and post-clinical study patient health values.

    Those values may be related to genomic information such as family health or known precursors relative to your condition. Data such as age, weight, ethnic background, gender, lifestyle, medications, and drug use will help formulate a comprehensive picture of the clinical study findings revealed at the study’s conclusion.

    The final report may include:

    • Comprehensive blood insulin levels
    • Changes in vision
    • Changes in personal health related to weight, eating habits, lifestyle
    • Any adverse effects.
    • Personal experience.
    • Enhanced risk factors
    • Health complications

  • How long do paid diabetes type 2 clinical trials last?

    Paid diabetes type 2 clinical trials do not have a set timeline with them and vary in length based on a myriad of factors such as:

    • Clinical trial design and type
    • Clinical sponsor
    • Type of drug intervention
    • Behavioral and lifestyle considerations

  • If I am interested in participating in a paid diabetes type 2 clinical trial, what questions should I ask?

    The clinical trial coordinator in charge of organizing your participation details welcomes any questions you may have. The NIH maintains clear guidance for orchestrating a transparent clinical trial experience with a strong emphasis on patient safety.

    Termed as informed consent, the clinical trial sponsors must disclose the following information:

    1. The comprehensive nature of the treatment, procedure, or drug.
    2. Any inherent risks associated with the intended treatment methods.
    3. Reasonable alternatives to the procedure or treatment intervention.
    4. Assessment and acknowledgment that you, the patient, are in complete understanding of items 1-3.

    Informed consent is required and articulates the agreement between you, your healthcare physician, and clinical trial sponsors. The purpose of informed consent is to provide the patient with the details of every facet of the intended clinical trial study plan. This goal of informed consent is to establish trust and confidence between the eligible participant and the clinical trial sponsor team leads.